{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:17:15Z","timestamp":1763968635321,"version":"3.41.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":85,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100917","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T19:47:54Z","timestamp":1743968874000},"page":"100917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring the prognostic significance of vitamin D deficiency in pancreatic cancer: Disease progression and survival outcomes"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-3152","authenticated-orcid":false,"given":"Aladeen","family":"Alloubani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baraa","family":"Abadalhaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Alshami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Fakhory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feras","family":"Abdalghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallak","family":"Almasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysa","family":"Alkouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2025.100917_bib0001","unstructured":"O. University, \u201cResearchers discover why pancreatic cancer cells are so aggressive,\u201d 2021. Accessed: Aug. 02, 2023. [Online]. Available: https:\/\/medicalxpress.com\/news\/2021-11-pancreatic-cancer-cells-aggressive.html."},{"issue":"10","key":"10.1016\/j.ctarc.2025.100917_bib0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.18632\/oncotarget.27518","article-title":"Prognostic and predictive factors in pancreatic cancer","volume":"11","author":"Dell'Aquila","year":"2020","journal-title":"Oncotarget."},{"issue":"27","key":"10.1016\/j.ctarc.2025.100917_bib0003","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors","volume":"27","author":"Hu","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"13","key":"10.1016\/j.ctarc.2025.100917_bib0004","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010114","article-title":"Vitamin intake and pancreatic cancer risk reduction: a meta-analysis of observational studies","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ctarc.2025.100917_bib0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejca.2020.10.038","article-title":"Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer","volume":"144","author":"Rasmussen","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100917_bib0006","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1245\/s10434-018-6431-8","article-title":"Vitamin D supplementation is a promising therapy for pancreatic ductal adenocarcinoma in conjunction with current chemoradiation therapy","volume":"25","author":"Mukai","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2025.100917_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9276380","article-title":"The biological activities of vitamin D and its receptor in relation to calcium and bone homeostasis, cancer, immune and cardiovascular systems, skin biology, and oral health","volume":"2018","author":"Khammissa","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100917_bib0008","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/0973-1482.38998","article-title":"Vitamin D and cancer","volume":"3","author":"Ali","year":"2007","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ctarc.2025.100917_bib0009","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpp.2017.11.005","article-title":"Vitamin D's role in health and disease: how does the present inform our understanding of the past?","volume":"23","author":"Lockau","year":"2018","journal-title":"Int. J. Paleopathol."},{"issue":"17","key":"10.1016\/j.ctarc.2025.100917_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174257","article-title":"Pancreatic cancer: challenges and opportunities in locoregional therapies","volume":"14","author":"Bazeed","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"11","key":"10.1016\/j.ctarc.2025.100917_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25850","article-title":"Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial","volume":"3","author":"Chandler","year":"2020","journal-title":"JAMA Netw. Open."},{"issue":"11","key":"10.1016\/j.ctarc.2025.100917_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112716","article-title":"Vitamin D: promises on the horizon and challenges ahead for fighting pancreatic cancer","volume":"13","author":"Wei","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2025.100917_bib0013","doi-asserted-by":"crossref","first-page":"e704","DOI":"10.1002\/onco.13645","article-title":"Analysis of the role of plasma 25-hydroxyvitamin D levels in survival outcomes in patients from the phase III MPACT trial of metastatic pancreatic cancer","volume":"26","author":"Von Hoff","year":"2021","journal-title":"Oncologist."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100917_bib0014","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s11033-012-1925-0","article-title":"Synergistic effect and mechanism of vitamin A and vitamin D on inducing apoptosis of prostate cancer cells","volume":"40","author":"Sha","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100917_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-021-00593-z","article-title":"The health effects of vitamin D supplementation: evidence from human studies","volume":"18","author":"Bouillon","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"11","key":"10.1016\/j.ctarc.2025.100917_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41430-020-0558-y","article-title":"Vitamin D deficiency 2.0: an update on the current status worldwide","volume":"74","author":"Amrein","year":"2020","journal-title":"Eur. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100917_bib0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11154-017-9415-2","article-title":"The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: a review of the epidemiology, clinical trials, and mechanisms","volume":"18","author":"Moukayed","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100917_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6040104","article-title":"A new role for vitamin D: the enhancement of oncolytic viral therapy in pancreatic cancer","volume":"6","author":"LaRocca","year":"2018","journal-title":"Biomedicines."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100917_bib0019","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/picr.PICR_124_18","article-title":"Study designs: part 1 \u2013 An overview and classification","volume":"9","author":"Ranganathan","year":"2018","journal-title":"Perspect. Clin. Res."},{"issue":"24","key":"10.1016\/j.ctarc.2025.100917_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246180","article-title":"Age-dependent impact of concomitant radio-chemotherapy and MGMT promotor methylation on PFS and OS in patients with IDH wild-type glioblastoma: the real-life data","volume":"14","author":"Krigers","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100917_bib0021","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09980-9","article-title":"Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States","volume":"22","author":"Medhekar","year":"2022","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.ctarc.2025.100917_bib0022","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.2147\/CMAR.S178979","article-title":"Comparison of clinical features and outcomes in patients with extraskeletal vs skeletal Ewing sarcoma: an SEER database analysis of 3178 cases","volume":"10","author":"Jiang","year":"2018","journal-title":"CMAR"},{"issue":"6","key":"10.1016\/j.ctarc.2025.100917_bib0023","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnci\/djad020","article-title":"Changes in survival in de novo metastatic cancer in an era of new medicines","volume":"115","author":"Luyendijk","year":"2023","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctarc.2025.100917_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.707214","article-title":"Immune checkpoint inhibitor in first-line treatment of metastatic renal cell carcinoma: a review of current evidence and future directions","volume":"11","author":"Tung","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2025.100917_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol30070455","article-title":"Tumor-associated macrophages in multiple myeloma: key role in disease biology and potential therapeutic implications","volume":"30","author":"Cencini","year":"2023","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100917_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/hematology.2022000347","article-title":"High or low? Assessing disease risk in multiple myeloma","volume":"2022","author":"Schmidt","year":"2022","journal-title":"Hematology."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100917_bib0027","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jnci\/djy087","article-title":"Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts","volume":"111","author":"McCullough","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100917_bib0028","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1159\/000438534","article-title":"Vitamin D deficiency and increased risk of bladder carcinoma: a meta-analysis","volume":"37","author":"Zhang","year":"2015","journal-title":"Cell Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100917_bib0029","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/0008-5472.CAN-18-2318","article-title":"A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk","volume":"79","author":"Travis","year":"2019","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100917_bib0030","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/ijc.31146","article-title":"Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations","volume":"142","author":"van Duijnhoven","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100917_bib0031","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10420","article-title":"Vitamin D and clinical cancer outcomes: a review of meta-analyses","volume":"5","author":"Sluyter","year":"2021","journal-title":"JBMR. Plus."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100917_bib0032","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3691","article-title":"The role of vitamin D in reducing cancer risk and progression","volume":"14","author":"Feldman","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2025.100917_bib0033","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","article-title":"Vitamin D signalling pathways in cancer: potential for anticancer therapeutics","volume":"7","author":"Deeb","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100917_bib0034","doi-asserted-by":"crossref","first-page":"89","DOI":"10.12997\/jla.2023.12.2.89","article-title":"Are only p-values less than 0.05 significant? A p-value greater than 0.05 is also significant!","volume":"12","author":"Kwak","year":"2023","journal-title":"J. Lipid Atheroscler."},{"issue":"38","key":"10.1016\/j.ctarc.2025.100917_bib0035","doi-asserted-by":"crossref","first-page":"64395","DOI":"10.18632\/oncotarget.18888","article-title":"Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:10:02Z","timestamp":1754061002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"alternative-id":["S2468294225000541"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100917","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the prognostic significance of vitamin D deficiency in pancreatic cancer: Disease progression and survival outcomes","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100917"}}